# Gates Industrial Corp Ltd.: financial statements, quarterly

GTES · NYSE · CIK 1718512 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gtes.md) · [Financials](/companies/gtes/financials.md) · [Filings](/companies/gtes/filings.md) · [Insiders](/companies/gtes/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gtes/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [873](/filings/0001718512-24-000084.md) | [863 d](/filings/0001628280-26-007719.md) | [863](/filings/0001718512-25-000031.md) | [886](/filings/0001718512-25-000051.md) | [831](/filings/0001628280-25-047174.md) | [829 d](/filings/0001628280-26-007719.md) | [848](/filings/0001628280-26-029351.md) | [884](/filings/0001628280-26-051411.md) | [856](/filings/0001628280-25-047174.md) | [856 d](/filings/0001628280-26-007719.md) | [851](/filings/0001628280-26-029351.md) | [942](/filings/0001628280-26-051411.md) |
| Cost of revenue | $m | [530](/filings/0001718512-24-000084.md) | [526 d](/filings/0001628280-26-007719.md) | [533](/filings/0001718512-25-000031.md) | [528](/filings/0001718512-25-000051.md) | [495](/filings/0001628280-25-047174.md) | [494 d](/filings/0001628280-26-007719.md) | [503](/filings/0001628280-26-029351.md) | [524](/filings/0001628280-26-051411.md) | [514](/filings/0001628280-25-047174.md) | [531 d](/filings/0001628280-26-007719.md) | [513](/filings/0001628280-26-029351.md) | [556](/filings/0001628280-26-051411.md) |
| Gross profit | $m | [343](/filings/0001718512-24-000084.md) | [338 d](/filings/0001628280-26-007719.md) | [330](/filings/0001718512-25-000031.md) | [357](/filings/0001718512-25-000051.md) | [336](/filings/0001628280-25-047174.md) | [335 d](/filings/0001628280-26-007719.md) | [345](/filings/0001628280-26-029351.md) | [360](/filings/0001628280-26-051411.md) | [342](/filings/0001628280-25-047174.md) | [325 d](/filings/0001628280-26-007719.md) | [338](/filings/0001628280-26-029351.md) | [386](/filings/0001628280-26-051411.md) |
| Selling, general and administrative | $m | [213](/filings/0001718512-24-000084.md) | [219 d](/filings/0001628280-26-007719.md) | [212](/filings/0001718512-25-000031.md) | [221](/filings/0001718512-25-000051.md) | [217](/filings/0001628280-25-047174.md) | [223 d](/filings/0001628280-26-007719.md) | [216](/filings/0001628280-26-029351.md) | [231](/filings/0001628280-26-051411.md) | [219](/filings/0001628280-25-047174.md) | [210 d](/filings/0001628280-26-007719.md) | [227](/filings/0001628280-26-029351.md) | [251](/filings/0001628280-26-051411.md) |
| Operating income | $m | [126](/filings/0001718512-24-000084.md) | [118 d](/filings/0001628280-26-007719.md) | [117](/filings/0001718512-25-000031.md) | [133](/filings/0001718512-25-000051.md) | [116](/filings/0001628280-25-047174.md) | [110 d](/filings/0001628280-26-007719.md) | [126](/filings/0001628280-26-029351.md) | [116](/filings/0001628280-26-051411.md) | [115](/filings/0001628280-25-047174.md) | [108 d](/filings/0001628280-26-007719.md) | [110](/filings/0001628280-26-029351.md) | [132](/filings/0001628280-26-051411.md) |
| Interest expense | $m | [39.5](/filings/0001718512-23-000065.md) | [38.4 d](/filings/0001718512-24-000010.md) | [37.5](/filings/0001718512-24-000036.md) | [49.1](/filings/0001718512-25-000051.md) | [35.1](/filings/0001628280-25-047174.md) | [34.1 d](/filings/0001628280-26-007719.md) | [29.6](/filings/0001628280-26-029351.md) | [28.8](/filings/0001628280-26-051411.md) | [34.9](/filings/0001628280-25-047174.md) | [32.6 d](/filings/0001628280-26-007719.md) | [29.9](/filings/0001628280-26-029351.md) | [30.0](/filings/0001628280-26-051411.md) |
| Income tax | $m | [1.0](/filings/0001718512-24-000084.md) | [2.4 d](/filings/0001628280-26-007719.md) | [34.5](/filings/0001718512-25-000031.md) | [12.3](/filings/0001718512-25-000051.md) | [14.0](/filings/0001628280-25-047174.md) | [46.7 d](/filings/0001628280-26-007719.md) | [25.2](/filings/0001628280-26-029351.md) | [16.8](/filings/0001628280-26-051411.md) | [6.1](/filings/0001628280-25-047174.md) | [15.0 d](/filings/0001628280-26-007719.md) | [11.5](/filings/0001628280-26-029351.md) | [(78.0)](/filings/0001628280-26-051411.md) |
| Net income | $m | [78.7](/filings/0001718512-24-000084.md) | [62.9 d](/filings/0001628280-26-007719.md) | [40.0](/filings/0001718512-25-000031.md) | [70.7](/filings/0001718512-25-000051.md) | [47.6](/filings/0001628280-25-047174.md) | [36.6 d](/filings/0001628280-26-007719.md) | [62.0](/filings/0001628280-26-029351.md) | [56.5](/filings/0001628280-26-051411.md) | [81.6](/filings/0001628280-25-047174.md) | [51.3 d](/filings/0001628280-26-007719.md) | [59.7](/filings/0001628280-26-029351.md) | [171](/filings/0001628280-26-051411.md) |
| Diluted EPS | $ per share | [0.29](/filings/0001718512-24-000084.md) | not reported | [0.15](/filings/0001718512-25-000031.md) | [0.26](/filings/0001718512-25-000051.md) | [0.18](/filings/0001628280-25-047174.md) | not reported | [0.24](/filings/0001628280-26-029351.md) | [0.22](/filings/0001628280-26-051411.md) | [0.31](/filings/0001628280-25-047174.md) | not reported | [0.23](/filings/0001628280-26-029351.md) | [0.67](/filings/0001628280-26-051411.md) |
| Basic EPS | $ per share | [0.30](/filings/0001718512-24-000084.md) | not reported | [0.15](/filings/0001718512-25-000031.md) | [0.27](/filings/0001718512-25-000051.md) | [0.18](/filings/0001628280-25-047174.md) | not reported | [0.24](/filings/0001628280-26-029351.md) | [0.22](/filings/0001628280-26-051411.md) | [0.32](/filings/0001628280-25-047174.md) | not reported | [0.24](/filings/0001628280-26-029351.md) | [0.67](/filings/0001628280-26-051411.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [557](/filings/0001718512-23-000065.md) | [721](/filings/0001718512-25-000013.md) | [522](/filings/0001718512-24-000036.md) | [580](/filings/0001718512-24-000065.md) | [574](/filings/0001718512-24-000084.md) | [682](/filings/0001628280-26-007719.md) | [640](/filings/0001718512-25-000031.md) | [720](/filings/0001718512-25-000051.md) | [689](/filings/0001628280-25-047174.md) | [812](/filings/0001628280-26-051411.md) | [785](/filings/0001628280-26-029351.md) | [824](/filings/0001628280-26-051411.md) |
| Current assets | $m | [2,318](/filings/0001718512-23-000065.md) | [2,401](/filings/0001718512-25-000013.md) | [2,287](/filings/0001718512-24-000036.md) | [2,377](/filings/0001718512-24-000065.md) | [2,401](/filings/0001718512-24-000084.md) | [2,306](/filings/0001628280-26-007719.md) | [2,368](/filings/0001718512-25-000031.md) | [2,522](/filings/0001718512-25-000051.md) | [2,485](/filings/0001628280-25-047174.md) | [2,482](/filings/0001628280-26-051411.md) | [2,489](/filings/0001628280-26-029351.md) | [2,709](/filings/0001628280-26-051411.md) |
| Total assets | $m | [7,109](/filings/0001718512-23-000065.md) | [7,255](/filings/0001718512-25-000013.md) | [7,046](/filings/0001718512-24-000036.md) | [7,035](/filings/0001718512-24-000065.md) | [7,122](/filings/0001718512-24-000084.md) | [6,786](/filings/0001628280-26-007719.md) | [6,886](/filings/0001718512-25-000031.md) | [7,218](/filings/0001718512-25-000051.md) | [7,150](/filings/0001628280-25-047174.md) | [7,151](/filings/0001628280-26-051411.md) | [7,115](/filings/0001628280-26-029351.md) | [7,393](/filings/0001628280-26-051411.md) |
| Current liabilities | $m | [780](/filings/0001718512-23-000065.md) | [779](/filings/0001718512-25-000013.md) | [748](/filings/0001718512-24-000036.md) | [763](/filings/0001718512-24-000065.md) | [796](/filings/0001718512-24-000084.md) | [722](/filings/0001628280-26-007719.md) | [710](/filings/0001718512-25-000031.md) | [729](/filings/0001718512-25-000051.md) | [705](/filings/0001628280-25-047174.md) | [735](/filings/0001628280-26-051411.md) | [679](/filings/0001628280-26-029351.md) | [835](/filings/0001628280-26-051411.md) |
| Total liabilities | $m | [3,697](/filings/0001718512-23-000065.md) | [3,711](/filings/0001718512-25-000013.md) | [3,551](/filings/0001718512-24-000036.md) | [3,541](/filings/0001718512-24-000065.md) | [3,664](/filings/0001718512-24-000084.md) | [3,446](/filings/0001628280-26-007719.md) | [3,458](/filings/0001718512-25-000031.md) | [3,606](/filings/0001718512-25-000051.md) | [3,435](/filings/0001628280-25-047174.md) | [3,462](/filings/0001628280-26-051411.md) | [3,387](/filings/0001628280-26-029351.md) | [3,499](/filings/0001628280-26-051411.md) |
| Long-term debt | $m | [2,418](/filings/0001718512-23-000065.md) | [2,415](/filings/0001718512-25-000013.md) | [2,313](/filings/0001718512-24-000036.md) | [2,310](/filings/0001718512-24-000065.md) | [2,342](/filings/0001718512-24-000084.md) | [2,312](/filings/0001628280-26-007719.md) | [2,308](/filings/0001718512-25-000031.md) | [2,305](/filings/0001718512-25-000051.md) | [2,204](/filings/0001628280-25-047174.md) | [2,196](/filings/0001628280-26-051411.md) | [2,198](/filings/0001628280-26-029351.md) | [2,194](/filings/0001628280-26-051411.md) |
| Current portion of debt | $m | [27.7](/filings/0001718512-23-000065.md) | [36.5](/filings/0001718512-25-000013.md) | [27.9](/filings/0001718512-24-000036.md) | [21.8](/filings/0001718512-24-000065.md) | [36.2](/filings/0001718512-24-000084.md) | [39.1](/filings/0001628280-26-007719.md) | [31.6](/filings/0001718512-25-000031.md) | [39.8](/filings/0001718512-25-000051.md) | [30.5](/filings/0001628280-25-047174.md) | [36.2](/filings/0001628280-26-051411.md) | [30.9](/filings/0001628280-26-029351.md) | [39.2](/filings/0001628280-26-051411.md) |
| Shareholders' equity | $m | [3,091](/filings/0001718512-23-000065.md) | [3,220](/filings/0001718512-25-000013.md) | [3,179](/filings/0001718512-24-000036.md) | [3,177](/filings/0001718512-24-000065.md) | [3,110](/filings/0001718512-24-000084.md) | [3,024](/filings/0001628280-26-007719.md) | [3,102](/filings/0001718512-25-000031.md) | [3,269](/filings/0001718512-25-000051.md) | [3,370](/filings/0001628280-25-047174.md) | [3,334](/filings/0001628280-26-051411.md) | [3,367](/filings/0001628280-26-029351.md) | [3,522](/filings/0001628280-26-051411.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [108 d](/filings/0001718512-24-000084.md) | [189 d](/filings/0001628280-26-007719.md) | [(21.0)](/filings/0001718512-25-000031.md) | [93.8 d](/filings/0001718512-25-000051.md) | [116 d](/filings/0001628280-25-047174.md) | [191 d](/filings/0001628280-26-007719.md) | [7.3](/filings/0001628280-26-029351.md) | [103 d](/filings/0001628280-26-051411.md) | [98.0 d](/filings/0001628280-25-047174.md) | [270 d](/filings/0001628280-26-007719.md) | [30.2](/filings/0001628280-26-029351.md) | [78.6 d](/filings/0001628280-26-051411.md) |
| Capital expenditure | $m | [15.2 d](/filings/0001718512-24-000084.md) | [21.6 d](/filings/0001628280-26-007719.md) | [16.0](/filings/0001718512-25-000031.md) | [21.9 d](/filings/0001718512-25-000051.md) | [21.9 d](/filings/0001628280-25-047174.md) | [23.3 d](/filings/0001628280-26-007719.md) | [17.5](/filings/0001628280-26-029351.md) | [19.4 d](/filings/0001628280-26-051411.md) | [17.5 d](/filings/0001628280-25-047174.md) | [18.8 d](/filings/0001628280-26-007719.md) | [16.7](/filings/0001628280-26-029351.md) | [18.3 d](/filings/0001628280-26-051411.md) |
| Share repurchases | $m | [0.0 d](/filings/0001718512-24-000084.md) | [0.0 d](/filings/0001628280-26-007719.md) | [50.3](/filings/0001718512-25-000031.md) | [0.0 d](/filings/0001718512-25-000051.md) | [126 d](/filings/0001628280-25-047174.md) | [0.0 d](/filings/0001628280-26-007719.md) | [13.0](/filings/0001628280-26-029351.md) | [0.0 d](/filings/0001628280-26-051411.md) | [0.0 d](/filings/0001628280-25-047174.md) | [106 d](/filings/0001628280-26-007719.md) | [16.6](/filings/0001628280-26-029351.md) | [22.1 d](/filings/0001628280-26-051411.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [285](/filings/0001718512-23-000065.md) | [288](/filings/0001718512-24-000036.md) | [280](/filings/0001718512-24-000065.md) | [268](/filings/0001718512-24-000084.md) | [267](/filings/0001718512-25-000031.md) | [267](/filings/0001718512-25-000051.md) | [263](/filings/0001628280-25-047174.md) | [262](/filings/0001628280-26-029351.md) | [260](/filings/0001628280-26-051411.md) | [262](/filings/0001628280-25-047174.md) | [257](/filings/0001628280-26-029351.md) | [256](/filings/0001628280-26-051411.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 253,151,170 at 2026-07-29, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051411.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.